Related Experiment Video

Updated: May 8, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

[Preeclampsia as cardiovascular risk factor]

Karst Y Heida1, Arie Franx, Michiel L Bots

  • 1Universitair Medisch Centrum Utrecht, Utrecht.

Nederlands Tijdschrift Voor Geneeskunde
|August 23, 2013
PubMed

Insights

Hypertensive disorders during pregnancy, including early preeclampsia, significantly increase cardiovascular disease risk in women. Current Dutch guidelines do not address screening or management for these high-risk individuals, necessitating urgent research.

Area of Science:

  • Cardiology
  • Obstetrics
  • Public Health

Background:

  • Cardiovascular diseases (CVD) are the leading cause of mortality in women.
  • Existing guidelines, like the Dutch Guideline on Cardiovascular Risk Management, identify diabetes mellitus (DM) and rheumatoid arthritis (RA) as CVD risk factors.
  • Hypertensive disorders during pregnancy, particularly early preeclampsia, are also established CVD risk factors, associated with a seven-fold increased risk of ischemic heart disease.

Purpose of the Study:

  • To highlight the need for cardiovascular risk management strategies for women with a history of hypertensive disorders during pregnancy.
  • To address the lack of guidelines and consensus in the Netherlands for screening and treating these women.
  • To emphasize the urgent requirement for clinical trial evidence to support cardiovascular risk management in this population.

Main Methods:

  • This study is a review and analysis of existing guidelines and evidence regarding cardiovascular risk factors in women.
  • It identifies a gap in current Dutch guidelines concerning the management of women with a history of hypertensive disorders during pregnancy.
  • It calls for the initiation of clinical trials to gather evidence on effective screening and treatment protocols.

Main Results:

  • Women with a history of hypertensive disorders during pregnancy face a significantly elevated risk of future cardiovascular diseases.
  • Early preeclampsia is linked to a substantial increase in the risk of developing ischemic heart disease.
  • There is a critical absence of established guidelines and consensus for managing cardiovascular risk in this demographic within the Netherlands.

Conclusions:

  • Women with a history of hypertensive disorders during pregnancy should be considered a high-risk group for cardiovascular diseases.
  • There is an urgent need for the development and implementation of screening and management guidelines for these women.
  • Further clinical research is essential to validate and refine cardiovascular risk management strategies for this vulnerable population.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...